To hear about similar clinical trials, please enter your email below
Trial Title:
Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning
NCT ID:
NCT00671385
Condition:
Breast Lesions
Breast Cyst
Early-Stage Breast Cancer
Benign Growth, Breast
Conditions: Official terms:
Breast Neoplasms
Breast Cyst
Conditions: Keywords:
screening
compositional analysis
metabolism
breast
breast cyst
breast infection
breast inflammation
lipoma
benign growth
Women without a diagnosis for a region of interest in the breast
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Prospective
Summary:
The purposes of this study is to establish normal optical values of breast tissue in the
general population. This will allow for establishing normals for breast composition, and
is expected to be useful in the classification of breast lesions into groups such as
cysts, benign growths, inflammatory lesions, and possibly early breast cancer.
Criteria for eligibility:
Study pop:
Women 18-50 with who EITHER (a) have a region of interest but without a diagnosis, or (b)
are healthy volunteers without breast cancer.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- You must be female
- You must be 21 to 50 years old
- You must not have or have had breast cancer.
- You must not have or have had breast implants or breast surgery
- You must not have had a breast biopsy or injury, or a breast infection, in 90 days.
Exclusion Criteria:
- Any one or more of the above conditions not met
- Lack of informed consent
Gender:
Female
Minimum age:
21 Years
Maximum age:
50 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Spectros Corporation
Address:
City:
Portola Valley
Zip:
94029
Country:
United States
Status:
Recruiting
Contact:
Last name:
Lizzy van Thillo, AA
Phone:
650-851-4040
Phone ext:
549
Email:
lizzy@spectros.com
Contact backup:
Last name:
Carrie Bomarito, RN
Phone:
640-851-4040
Phone ext:
0
Email:
info@spectros.com
Start date:
April 2008
Completion date:
April 2011
Lead sponsor:
Agency:
Spectros Corporation
Agency class:
Industry
Collaborator:
Agency:
Stanford University
Agency class:
Other
Collaborator:
Agency:
University of California
Agency class:
Other
Collaborator:
Agency:
Palo Alto Medical Foundation
Agency class:
Other
Source:
Spectros Corporation
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00671385
http://www.firstscan.net
